🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Novo Nordisk supply chain update — semaglutide availability Q2 2026 Page 8

Novo Nordisk supply chain update — semaglutide availability Q2 2026

Admin Mon, Feb 26, 2024 at 4:00 PM 278 replies 41,224 viewsPage 8 of 20
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Mar 26, 2024 at 9:57 PM#36
Dr.PeteFamMed said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

25 23Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 22 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Mar 28, 2024 at 9:59 AM#37

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

26 24NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 23 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Mar 29, 2024 at 10:00 PM#38

One thing that is still open after Dr.PeteFamMed’s answer:

How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?

27 0AttorneyGrant, DebRD_ATL, KristenIndy and 24 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Mar 31, 2024 at 10:00 AM#39
PeptideSynthNJ said:
Practical: whatever you change, write down the date and the reason.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

Last edited: Mar 31, 2024 at 1:00 PM
28 1amy_econ_NJ, bbq_ray_KC, oliver_london and 25 others
Reply Quote Save Share Report
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Apr 1, 2024 at 9:59 PM#40
PeptideSynthNJ said:
Practical: whatever you change, write down the date and the reason.

PeptideSynthNJ has the substance of this right. The condition it depends on is worth stating. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

50 23Dr.LeslieOBGYN, MikeNYC_runner and 47 others
Reply Quote Save Share Report
167891020

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register